DGDavid Andrés González

David Andrés González

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David Andrés González has a total of 99 co-authors. Here are the top co-authors by number of shared publications:

  • Christopher G. Goetz

    Division of Movement Disorders, Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA

    5 shared publications
  • Jason R. Soble

    University of Illinois

    5 shared publications
  • Abhimanyu Mahajan

    James J. and Joan A. Gardner Family Center for Parkinson's Disease and Movement Disorders University of Cincinnati Cincinnati Ohio USA

    4 shared publications
  • Jason R. Soble

    Departments of Psychiatry & Neurology (JRS), University of Illinois College of Medicine, Chicago, IL, USA

    4 shared publications
  • Cynthia Comella

    Division of Movement Disorders, Department of Neurological Sciences Rush University Medical Center Chicago Illinois USA

    3 shared publications
  • Mitzi M. Gonzales

    Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA; Department of Neurology, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA

    3 shared publications

Latest Publications

  • Reliability, Validity and Determinants of Self‐Reported Autonomic Dysfunction in Prodromal and Established Parkinson's Disease

    by Abhimanyu Mahajan, Aimee J. Karstens, David Andrés González

    Background: Scales for Outcomes in Parkinson's Disease Autonomic Dysfunction Scale (SCOPA‐AUT) is a widely used, self‐reported scale to evaluate autonomic dysfunction in PD. Recent literature on interoception has raised questions about validity. Several knowledge gaps remain minimal detectable change (MDC), best subscale structure, validation against objective autonomic measures, and performance in prodromal populations. Objective: To critically expand knowledge of SCOPA‐AUT's measurement properties with novel analyses to increase confidence as an outcome measure. Methods: Data from the Parkinson's Progression Markers Initiative (PPMI) were analyzed. Exploratory and confirmatory factor analyses determined subscale structure. Test–retest reliability helped derive the MDC. Criterion and construct validity were assessed using objective measures (e.g., orthostatic hypotension (OH)) with area‐under‐the‐curves and correlations. Mixed models identified the best predictors of self‐reported autonomic dysfunction. Results: Data on 4450 individuals, including healthy controls ( n = 343), prodromal ( n = 2539) and established PD ( n = 1503) participants, were analyzed. The total scale had strong reliability ( ω = 0.86; ICC = 0.78), with an MDC≥6. The published six‐subscale structure showed adequate fit, but splitting the gastrointestinal domain into upper (oral) and lower (intestinal) factors significantly improved model fit. Criterion validity against objective OH was poor (AUC = 0.59). SCOPA‐AUT correlated most strongly with non‐motor experiences of daily living ( r s = 0.62, large effect), which was also its strongest longitudinal predictor, followed by motor experiences of daily living. Conclusions: SCOPA‐AUT is a reliable, valid scale in prodromal and established PD. The published subscale, while adequate, may benefit from modification. SCOPA‐AUT correlates robustly with non‐motor, followed by motor experiences of daily living, supporting its continued use.

  • Best practice recommendations for spoken and signed language interpreter-mediated clinical neuropsychological services

    by Adriana M. Strutt, Lawrence H. Pick, Jesus Barreto Abrams, Kendra M. Anderson, David Andrés González, Audrina Mullane, Margaret Baker Daniel, Stephen R. McCauley

    The United States is experiencing a steady rise in cultural and linguistic diversity. According to the U.S. Census Bureau, 21.7% of households across the country use a language other than English a...

  • The Lawton and Brody a half century later: A case for contemporary revision

    by Jared F. Benge, Amy E. Werry, Gabrielle Hromas, Alyssa Aguirre, Cecilia Zuniga, Robin C. Hilsabeck, David Andrés González

    Objective: To reevaluate the psychometric properties and contemporary relevance of the 1969 Lawton and Brody Instrumental Activities of Daily Living (iADL) Scale in older adults. Methods: Data from 3552 participants and co-participants in the Texas Alzheimer's Research and Care Consortium cohort were analyzed. Lawton and Brody iADL Scale items were analyzed in a sample with no cognitive disorder, mild cognitive impairment, and dementia. Graded response models assessed item discrimination and difficulty, with differential item functioning (DIF) analyses examining demographic effects. Expert reviewers evaluated item content for cultural and technological relevance. Results: Items assessing shopping, food preparation, and transportation were most sensitive to mild functional impairment, while the total scale had limited detection of subtle functional decline. Statistical DIF emerged on 75% of items, whereas clinically meaningful DIF for several demographic groupings emerged on the transportation item. Expert reviewers identified outdated content, particularly for telephone and financial items, reflecting technological shifts. Broader changes in normative behaviors and sample demographics may further challenge scale applicability. Conclusions: The Lawton and Brody iADL Scale remains foundational but shows limited sensitivity for early functional decline. Outdated items and evolving socioeconomic and technological contexts underscore the need for refinement to enhance unbiased early detection and maintain longitudinal comparability. Updating the instrument to reflect modern demands could strengthen functional assessment in Alzheimer's disease and related disorders research and clinical trials.

  • Open Access

    Loneliness predicts worse Parkinsonism: a longitudinal, community-based, clinical-pathological study

    by David Andrés González, Robert S. Wilson, Jessica Hemm, Christopher G. Goetz

    Loneliness is increasingly acknowledged as important in parkinsonism-related disorders. However, little is known about reciprocal longitudinal relationships between loneliness and parkinsonism. In this study, 3,099 community-based individuals (Mage=78.09, 75.2% women) completed measures of loneliness, isolation, depression and were rated on parkinsonism severity annually with 846 having available postmortem data. Controlling for demographic and social-emotional covariates, mixed multilevel modeling evaluated longitudinal impacts of parkinsonism on loneliness and loneliness on parkinsonism. The loneliness→parkinsonism models explained greater variance, with loneliness associated with worse parkinsonism and greater rates of motor decline. Whereas parkinsonism→loneliness models revealed worse parkinsonism associated with worse loneliness, parkinsonism did not predict rate of loneliness change. Subjects with Lewy Bodies at autopsy had worse loneliness proximate to death and a more pronounced time×loneliness interaction compared to those without. There are bidirectional relationships between loneliness and parkinsonism, with loneliness being the more potent longitudinal predictor.


  • A preliminary examination of the psychometrics and cognitive correlates of an abbreviated version of the verbal naming test administered via telephone

    by Dhruvi M Mehta, Jennifer L Thompson Kamar, Troy A Webber, Romeo Penheiro, Natalie C Ridgely, David Andrés González, Steven Paul Woods

    Objective: Confrontational naming is an important part of many neuropsychological evaluations. Yet, data on the feasibility and psychometric properties of telephone-based confrontational verbal naming tests (VNTs) are quite limited. The current study conducted a preliminary, exploratory examination of the psychometrics and correlates of an abbreviated version of the 50-item VNT administered via telephone. Method: Participants were 220 healthy adults, including 110 younger adults (ages 18–35) and 110 middle-aged to older adults (ages 50–85). Participants completed a 15-item version of the VNT as part of a broader telephone-based cognitive battery. Results: Confirmatory factor analysis suggested support for a 12-item model of the VNT (VNT-T12) with acceptable fit. VNT-T12 scores were negatively skewed and demonstrated good internal consistency. A quantile regression predicting VNT-T12 from domain-level cognitive variables showed that executive functions (e.g., verbal fluency) and fund of verbal knowledge were significantly and positively associated with VNT-T12 scores at most percentile ranges. The VNT-T12 scores were also significantly associated with race/ethnicity and English as a second language at higher quantiles of performance. Demographically-adjusted coefficients and an associated calculator are provided as a normative resource. Conclusions: Findings provide mixed and preliminary support for the feasibility, psychometrics, and validity of a 12-item VNT administered via telephone. Future research on the psychometrics and validity of the VNT-T12 is warranted in samples with lower levels of education and in clinical populations.

  • Linking traditional and technological activities of daily living: Building modern, adaptable measures of daily functioning

    by David Andrés González, Cecilia Zuniga, Logan Marie Tufty, Robin C. Hilsabeck, Jared F. Benge

    Objectives: Instrumental activities of daily living (iADLs) are critical in aging and neurodegenerative research, both diagnostically (e.g., distinguishing dementia from mild cognitive impairment) and as endpoints for trials maintaining or improving functioning. However, measurement has not consistently kept pace with a changed world wherein the ability to navigate technology is pertinent to maintaining independent functioning. The current study used harmonization approaches to link traditional and technological iADLs measures using two samples. Methods: 262 individuals (53.4% women, 91.7% non-Hispanic White, M age = 76.2, M education = 15.6) completed both measures: (1), the Functional Activities Questionnaire (FAQ), and (2), the new Expanded FAQ. Item response theory (IRT) analyses extracted item parameters to characterize measure psychometrics and accurately determine individual functional ability. Harmonization was done using both nonequivalent groups anchor test (NEAT) and equipercentile linking methods with supplementary traditional iADL parameter estimates from the National Alzheimer Coordinating Center ( n = 48,605). Results: Correlations verified the measures were sufficiently related ( r s = .79), and confirmatory factor analyses and reliability determined all items assessed a single construct. Items from both measures complemented each other to provide more information about milder and more severe functional change. NEAT models converged to provide IRT linking equations and equipercentile conversation tables. Conclusion: This study provides critical information for harmonizing evolving technological iADLs with traditional iADLs that are assessed in longstanding cohorts. It further provides support for use of an expanded FAQ.


  • Open Access

    Investigating Sleep Concerns in Cervical Dystonia

    by Abhimanyu Mahajan, David Andrés González, Cynthia Comella

    Background: Heterogenous, small cohorts, and co‐occurrence of pain and psychiatric burden complicate understanding of sleep in dystonia. Objective: To investigate sleep concerns in cervical dystonia (CD). Methods: Longitudinal data from CD‐PROBE on subjects who were toxin‐naïve, new to practice, or without injections for at least 16 weeks were analyzed. Cervical Dystonia Impact Profile captured sleep disturbances. Impact of OnabotulinumtoxinA on sleep was assessed using multilevel mixed models, controlling for demographics, dystonia severity, mood, and pain. Results: 56% (n = 1037) reported concerns with sleep initiation, restfulness, maintenance, and total time. Initial injection led to a clear improvement in sleep. ( P < 0.001) Motor severity (β: 0.20, P < 0.001), mood (β: 0.36, P < 0.001), and pain (β: 0.58, P < 0.001) predicted sleep improvement (n = 502) over three OnabotulinumtoxinA cycles. Conclusions: Sleep concerns are common in CD, with initial and subsequent improvement with OnabotulinumtoxinA. Impact of mood and pain on sleep highlights the importance of non‐motor features.


  • The Neuropsychiatric Inventory Questionnaire (NPI-Q)

    by David Andrés González, David Andrés, Maximillian A. Obolsky, Nicholas R. Amitrano, John-Christopher A. Finley, Jason R. Soble

  • Open Access

    The Parkinson's Disease Cognitive Composite: Lessons Forgotten from Preclinical Alzheimer's Cognitive Composites

    by David Andrés González, Aimee J. Karstens, Samantha Evy Schoeneman Patel, Jori E. Fleisher, Christopher G. Goetz


  • Loneliness in Parkinson's disease: Subjective experience overshadows objective motor impairment

    by David Andrés González, Michelle H.S. Tosin, Tila Warner-Rosen, Mitra Afshari, Brandon Barton, Jori E. Fleisher, Deborah A. Hall, Alana E. Kirby, Katie Kompoliti, Abhimanyu Mahajan, et al.